Clinical Trial Update: An Exploratory Study of Telaprevir in Treatment-Naive Participants With Chronic Genotype 4 Hepatitis C Virus Infection [Phase 2]

View source ↗

Summary

An update on a Phase 2 exploratory trial of telaprevir in treatment-naive adults with chronic genotype 4 hepatitis C, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: Tibotec BVBA | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2013-07-12